StockMarketWire.com - Allergy Therapeutics finance director Ian Postlethwaite has resigned to pursue a new opportunity.

He will remain as finance director for up to six months to allow time for a suitable successor to be appointed and for an orderly handover. The board has started a search for his successor and a further announcement will be made in due course.

Chairman Peter Jensen said: "Ian has been the Finance Director for 14 years and a significant contributor to the success of the company. During this time Allergy Therapeutics has listed on AIM, achieved a number of financial goals including two fund raisings in 2015 to support the company's clinical and other development plans, and has growing revenues from products on sale in Europe. Ian leaves the company in the strongest position it has ever been in, in terms of sales, cash balance and growth potential. We are very positive about the future of Allergy Therapeutics and wish Ian the best for his ongoing career."


At 9:29am: [LON:AGY] Allergy Therapeutics PLC share price was 0p at 26.75p



Story provided by StockMarketWire.com